on Aap Implantate AG (ETR:AAQ)
Aap Implantate AG Announces Management Board Changes
aap Implantate AG has announced a significant shift in its Management Board. Mr. Rubino Di Girolamo will step down from his roles as a board member and Chief Executive Officer effective December 31, 2026. His resignation has been agreed upon with the Supervisory Board and marks an early departure.
The Supervisory Board has swiftly appointed Mr. Cornelius Fink as a new member of the Executive Board. Fink will lead the Trauma division. Additionally, Ms. Nicole Kassel joins the Board of Management, assuming responsibility as the Chief Financial Officer.
This reshuffle indicates a strategic repositioning within the company, aiming to refine operational focus and enhance its financial oversight. The appointments are effective immediately, signaling a decisive move by the Supervisory Board to ensure continued leadership and growth.
R. E.
Copyright © 2026 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all Aap Implantate AG news